Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against staphylococci

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1539-1547

  Sandiford, Stephanie ^a,b   Upton, Mathew ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; CHLORTETRACYCLINE; EPIDERMICIN NI01; LYSINE DERIVATIVE; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; POLYPEPTIDE ANTIBIOTIC AGENT; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CATION EXCHANGE; DRUG IDENTIFICATION; ENTEROCOCCUS FAECALIS; GENE SEQUENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; TANDEM MASS SPECTROMETRY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIOCINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DISCOVERY; ENTEROCOCCUS; ESCHERICHIA COLI; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PLASMIDS; PROTEIN STABILITY; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN RESISTANCE;

EID: 84857175322     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05397-11     Document Type: Article

References (51)

1. Allgaier H, Jung G, Werner RG, Schneider U, Zahner H. 1986. Epidermin: sequencing of a heterodet tetracyclic 21-peptide amide antibiotic. Eur. J. Biochem. 160:9-22. (Pubitemid 17177444)
2. Bastos MC, Ceotto H, Coelho ML, Nascimento JS. 2009. Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological application. Curr. Pharm. Biotechnol. 10:38-61.
3. Bommarius B, et al. 2010. Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31: 1957-1965.
4. Brink M, Todorov SD, Martin JH, Senekal M, Dicks LM. 2006. The effect of prebiotics on production of antimicrobial compounds, resistance to growth at low pH and in the presence of bile, and adhesion of probiotic cells to intestinal mucus. J. Appl. Microbiol. 100:813-820.
5. Butcher BG, Helmann JD. 2006. Identification of Bacillus subtilis W-dependent genes that provide intrinsic resistance to antimicrobial compounds produced by bacilli. Mol. Microbiol. 60:765-782.
6. Chikindas ML, et al. 1993. Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC1.0, forms hydrophilic pores in the cytoplasmic membrane of target cells. Appl. Environ. Microbiol. 59:3577-3584. (Pubitemid 23327552)
7. Daly KM, et al. 2010. Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J. Bacteriol. 192:1131-1142.
8. Delves-Broughton J, Blackburn P, Evans RJ, Hugenholtz J. 1996. Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 69:193-202. (Pubitemid 26058497)
9. Drider D, Fimland G, Hechard Y, McMullen LM, Prevost H. 2006. The continuing story of class IIa bacteriocins. Microbiol. Mol. Biol. Rev. 70: 564-582. (Pubitemid 43895038)
10. Ekkelenkamp MB, et al. 2005. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis. FEBS Lett. 579:1917-1922. (Pubitemid 40404031)
11. Fernandez-Lopez S, et al. 2001. Antibacterial agents based on the cyclic D,L-[alpha]-peptide architecture. Nature 412:452-455. (Pubitemid 32702711)
12. Fimland G, Eijsink VGH, Nissen-Meyer J. 2002. Mutational analysis of the role of tryptophan residues in an antimicrobial peptide. Biochemistry 41:9508-9515. (Pubitemid 34810026)
13. Fleury Y, et al. 1996. Covalent structure, synthesis, and structure-function studies of mesentericin Y 10537, a defensive peptide from Grampositive bacteria Leuconostoc mesenteroides. J. Biol. Chem. 271:14421-14429.
14. Fontana MB, de Bastos Mdo C, Brandelli A. 2006. Bacteriocins pep5 and Epidermin inhibit Staphylococcus epidermidis adhesion to catheters. Curr. Microbiol. 52:350-353.
15. Fox JL. 2006. The business of developing antibacterials. Nat. Biotechnol. 24:1521-1528. (Pubitemid 44967475)
16. Fujita K, et al. 2007. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl. Environ. Microbiol. 73:2871-2877. (Pubitemid 46718569)
17. Haas CE, Nix DE, Schentag JJ. 1990. In vitro selection of resistant Helicobacter pylori. Antimicrob. Agents Chemother. 34:1637-1641. (Pubitemid 20259485)
18. Heidrich C, et al. 1998. Isolation, characterisation and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl. Environ. Microbiol. 64:3140-3146. (Pubitemid 28411427)
19. Heng NCK, Tagg JR. 2006. What's in a name? Class distinction for bacteriocins. Nat. Rev. Microbiol. doi:10.1038/nrmicro1273-c1.
20. Hyink O, Balakrishnan M, Tagg JR. 2005. Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. FEMS Microbiol. Lett. 252:235-241. (Pubitemid 41531649)
21. Iwatani S, Zendo T, Yoneyama F, Nakayama J, Sonomoto K. 2007. Characterisation and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU14. Biosci. Biotechnol. Biochem. 71: 1984-1992. (Pubitemid 350113164)
22. Jack RW, Tagg JR, Ray B. 1995. Bacteriocins of Gram-positive bacteria. Microbiol. Rev. 59:171-200.
23. Jiang Z, et al. 2008. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α-helical cationic antimicrobial peptides. Biopolymers 90:369-383.
24. Kaletta C, et al. 1989. Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch. Microbiol. 152:16-19.
25. Kellner R, et al. 1988. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 177:53-59.
26. Klaenhammer TR. 1993. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12:39-85. (Pubitemid 23266726)
27. Kuroda M, et al. 2005. Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection. Proc. Natl. Acad. Sci. U. S. A. 102:13272-13277. (Pubitemid 41325013)
28. Majeed H, Gillor O, Kerr B, Riley MA. 2011. Competitive interactions in Escherichia coli populations: the role of bacteriocins. ISME J. 5:71-81.
29. Marquez B. 2005. Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87:1137-1147. (Pubitemid 41572643)
30. Mayr-Harting A, Hedges AJ, Berkeley RCW, Norris JR, Ribbons DW. 1972. Methods for studying bacteriocins, p 315-422. In Norris JR, RibbonsDW (ed), Methods in microbiology. Academic Press, New York, NY.
31. Minamikawa M, Kawai Y, Inoue N, Yamazaki K. 2005. Purification and characterization of Warnericin RB4, anti-Alicyclobacillus; bacteriocin, produced by Staphylococcus warneri; RB4. Curr. Microbiol. 51:22-26. (Pubitemid 41160034)
32. Morisset D, Berjeaud J-M, Marion D, Lacombe C, Frere J. 2004. Mutational analysis of mesentericin Y105, an anti-listeria bacteriocin, for determination of impact on bactericidal activity, in vitro secondary structure, and membrane interaction. Appl. Environ. Microbiol. 70:4672-4680. (Pubitemid 39095491)
33. Nascimento JS, et al. 2006. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains. Lett. Appl. Microbiol. 42:215-221.
34. Navaratna M, Sahl HG, Tagg JR. 1998. Two-component Anti Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl. Environ. Microbiol. 64:4803-4808. (Pubitemid 28557842)
35. Netz DJ, Bastos Mdo C, Sahl HG. 2002. Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus. Appl. Environ. Microbiol. 68:5274-5280. (Pubitemid 35265657)
36. Netz DJ, et al. 2002. Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J. Mol. Biol. 319:745-756. (Pubitemid 34729447)
37. Oh D, et al. 2000. Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures. Biochemistry 39:11855-11864.
38. Parente E, Hill C. 1992. A comparison of factors affecting the production of two bacteriocins from lactic acid bacteria. J. Appl. Microbiol. 73:290-298.
39. Risøen PA, Rønning P, Hegna IK, Kolstø AB. 2004. Characterization of a broad range antimicrobial substance from Bacillus cereus. J. Appl. Microbiol. 96:648-655.
40. Sato H, Feix JB. 2008. Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Antimicrob. Agents Chemother. 52: 4463-4465.
41. Tagg J, Dajani A, Wannamaker L. 1976. Bacteriocins of gram-positive bacteria. Bacteriol. Rev. 40:722-756.
42. Tencza SB, et al. 1999. Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerization. J. Antimicrob. Chemother. 44:33-41. (Pubitemid 29353680)
43. Todorov SD, et al. 2010. Chracterisation of an antiviral pediocin-like bacteriocin produced by Enterococcus faecium. Food Microbiol. 27:869-879.
44. van de Kamp M, et al. 1995. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7 cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur. J. Biochem. 230:587-600.
45. Verdon J, Berjeaud J-M, Lacombe C, Héchard Y. 2008. Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri. Peptides 29:978-984.
46. Wescombe P, et al. 2006. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek 90: 269-280. (Pubitemid 44314604)
47. Yoneyama F, et al. 2009. Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors. Appl. Environ. Microbiol. 75:538-541.
48. Yoneyama F, et al. 2009. Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Antimicrob. Agents Chemother. 53:3211-3217.
49. Yoneyama F, et al. 2011. Lacticin Q-mediated selective toxicity depending on physicochemical features of membrane components. Antimicrob. Agents Chemother. 55:2446-2450.
50. Young J, Holland IB. 1999. ABC transporters: bacterial exporters-revisited five years on. Biochem. Biophys. Acta 1461:177-200.
51. Zasloff M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U. S. A. 84:5449-5453. (Pubitemid 17129018)